ILMN.NASDAQIllumina, INC

Form 4: Illumina Director Scott B. Ullem Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Director Scott B. Ullem reports acquisition and disposal of Illumina (ILMN) common stock and grant of restricted stock units.

Summary

  • On May 16, 2024, Scott B. Ullem, a director of Illumina, Inc., reported changes in beneficial ownership of the company's stock.
  • Ullem acquired 2,622 shares of common stock through a grant of restricted stock units at a price of $0.
  • He also disposed of 4,292 shares of common stock.
  • Following these transactions, Ullem beneficially owns 4,292 shares of Illumina common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. The acquisition of shares through restricted stock units is mildly positive, while the disposal of shares is mildly negative, balancing each other out.

Positives

  • The grant of restricted stock units aligns the director's interests with the company's performance.

Negatives

  • The disposal of 4,292 shares could be interpreted negatively by some investors, although the reason for disposal is not specified.

Risks

  • The document does not explicitly mention any risks.
  • However, any disposal of shares by a director could be perceived as a lack of confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of restricted stock units is tied to continued service as a director and the company's annual meeting schedule.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company.

Key Dates

DateDescription
05/16/2024Date of stock acquisition and disposal, and grant of restricted stock units.
05/17/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.